相关实验视频
Updated: May 6, 2026

14:14
Optimized Fibrin Gel Bead Assay for the Study of Angiogenesis
Published on: April 29, 2007
31.8K
在没有并发症的怀孕中确定纤维素单体的预期值
Holger Seidel1, Melina Duncklenberg1, Hans-Jörg Hertfelder1
1Centrum für Blutgerinnungsstörungen und Transfusionsmedizin, Bonn, Germany.
概括
与其他标志物不同,纤维素单体 (FM) 水平在怀孕期间保持稳定,为评估静脉血栓栓塞 (VTE) 风险提供了更可靠的指标. 遗传性血栓友爱会比其他危险因素更多地影响血静.
科学领域:
- 产科和妇科 产科和妇科
- 血液学 血液学 血液学
- 血栓形成研究研究
背景情况:
- 怀孕期间血液静止激活标志物 (MAM) 的生理上升可能会影响静脉血栓塞栓症 (VTE) 风险评估.
- D-二次数 (DD) 广泛使用,但由于与怀孕相关的波动,可能不可靠.
- 纤维素单体 (FM) 水平在怀孕期间表现出稳定性,这表明它有可能成为可靠的生物标志物.
研究的目的:
- 在孕妇门诊患者中建立纤维素单体 (FM) 水平的参考范围.
- 研究VTE风险评分 (RCOG) 和抗血栓治疗对FM水平的影响.
- 为了比较整个怀孕期间的FM水平与其他MAM的稳定性.
主要方法:
- 分析了来自350个怀孕的342名孕妇的899个样本.
- 包括皇家妇产科医生学院 (RCOG) 风险评分和抗血栓治疗数据.
- 计算FM的参考范围,并与其他MAM进行比较.
主要成果:
- 纤维素单体 (FM) 水平允许稳定的参考范围计算,独立于妊娠期.
- 低风险的血栓友爱影响了所有MAM,而抗血栓治疗只影响了DD水平.
- 与其他MAM不同的是,FM水平在整个怀孕期间的波动很小.
结论:
- 遗传性血栓友病对怀孕血静有比获得风险因素更大的影响.
- 纤维素单体 (FM) 是一个潜在的候选人,可以改进实验室对怀孕期间VTE风险的评估.
- 对于怀孕的怀疑VTE的患者,需要进行进一步的前性研究.
相关概念视频
Teratogenicity
4.2K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.2K
Development of Immunocompetence
1.2K
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.2K
Development of Human Microbiota
73
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
73
Development of the Oral Microbiota
75
The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
75

